The pandemic year has turned the conventional way of developing vaccines on its head. Though immunisation worldwide is a paediatric medical event, the first Covid-19 shots developed were for people aged 18 years and above.
Work on paediatric versions of Covid-19 vaccine, however, is not far behind, according to vaccine manufacturers in the race. A leading vaccine maker, which is in the final leg of developing a Covid-19 vaccine, said: “Once the immunisation programme starts and one can observe the vaccines in use on a mass-scale, the safety of these investigational products would be established beyond doubt. It is around the